Phreesia Inc (PHR)
19.53
-0.19
(-0.96%)
USD |
NYSE |
Jun 14, 16:00
19.51
-0.02
(-0.10%)
Pre-Market: 20:00
Phreesia Revenue (TTM): 373.67M for April 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| April 30, 2024 | 373.67M |
| January 31, 2024 | 356.30M |
| October 31, 2023 | 337.88M |
| July 31, 2023 | 319.36M |
| April 30, 2023 | 301.40M |
| January 31, 2023 | 280.91M |
| October 31, 2022 | 262.34M |
| July 31, 2022 | 245.16M |
| April 30, 2022 | 228.30M |
| January 31, 2022 | 213.23M |
| October 31, 2021 | 197.02M |
| Date | Value |
|---|---|
| July 31, 2021 | 179.57M |
| April 30, 2021 | 163.57M |
| January 31, 2021 | 148.68M |
| October 31, 2020 | 139.68M |
| July 31, 2020 | 134.06M |
| April 30, 2020 | 129.87M |
| January 31, 2020 | 124.79M |
| October 31, 2019 | 118.45M |
| July 31, 2019 | 110.37M |
| April 30, 2019 | 104.33M |
| January 31, 2019 | 99.89M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
110.37M
Minimum
Jul 2019
373.67M
Maximum
Apr 2024
218.23M
Average
205.13M
Median
Revenue (TTM) Benchmarks
| American Shared Hospital Services | 21.62M |
| Novo Integrated Sciences Inc | 13.66M |
| Astrana Health Inc | 1.454B |
| Cryo-Cell International Inc | 31.37M |
| P3 Health Partners Inc | 1.353B |